ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.620
+0.140 (9.46%)
Dec 20, 2024, 4:00 PM EST - Market closed

ALX Oncology Holdings Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
72
Market Cap
85.44M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 20201.18M-3.61M-75.35%
Dec 31, 20194.80M2.73M132.03%
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
So-Young International 212.14M
23andMe Holding Co. 193.26M
Assertio Holdings 125.76M
InspireMD 6.82M
Adlai Nortye 5.00M
I-Mab 3.31M
Ikena Oncology 659.00K
Entera Bio 99.00K
Revenue Rankings